Cargando…

Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition

BACKGROUND: Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Micháliková, Dominika, Tyukos Kaprinay, Barbara, Lipták, Boris, Švík, Karol, Slovák, Lukáš, Sotníková, Ružena, Knezl, Vladimír, Gaspárová, Zdenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921224/
https://www.ncbi.nlm.nih.gov/pubmed/31885479
http://dx.doi.org/10.1016/j.jsps.2019.10.002
_version_ 1783481113980698624
author Micháliková, Dominika
Tyukos Kaprinay, Barbara
Lipták, Boris
Švík, Karol
Slovák, Lukáš
Sotníková, Ružena
Knezl, Vladimír
Gaspárová, Zdenka
author_facet Micháliková, Dominika
Tyukos Kaprinay, Barbara
Lipták, Boris
Švík, Karol
Slovák, Lukáš
Sotníková, Ružena
Knezl, Vladimír
Gaspárová, Zdenka
author_sort Micháliková, Dominika
collection PubMed
description BACKGROUND: Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well explored. We decided to test effect of rutin compared to the effect of the standard drug atorvastatin. METHODS: As a model of metabolic syndrome we used males of hypertriacylglycerolemic rats in combination with high-fat-high-fructose diet. Rutin (100 mg/kg) and atorvastatin (50 mg/kg) were administered orally daily for 5 weeks. RESULTS: We determined biochemical parameters from blood: HDL-cholesterol, LDL-cholesterol, total cholesterol, triacylglycerols. Relaxation and contraction response of aorta was measured to determine vessel dysfunctions and possible predisposition to cardiovascular disease. The negative influence on cognitive functions could be associated with the development of metabolic cognitive syndrome. Therefore we aimed to monitor spatial memory by Morris water maze test. Both rutin and atorvastatin had a tendency to decrease levels of serum triacylglycerols, but only atorvastatin significantly reduced levels od LDL-cholesterol and increased HDL-cholesterol levels. Both compounds significantly reduced the phenylephrine-induced contractile response of the aorta and improved the relaxation response. Further, treated animals learned better compared to untreated rats in the Morris water maze. CONCLUSION: Based on our results we can assume that atorvastatin and rutin had positive effect on spatial memory and vessel reactivity. Atorvastatin optimized lipid profile of blood serum.
format Online
Article
Text
id pubmed-6921224
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69212242019-12-27 Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition Micháliková, Dominika Tyukos Kaprinay, Barbara Lipták, Boris Švík, Karol Slovák, Lukáš Sotníková, Ružena Knezl, Vladimír Gaspárová, Zdenka Saudi Pharm J Article BACKGROUND: Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well explored. We decided to test effect of rutin compared to the effect of the standard drug atorvastatin. METHODS: As a model of metabolic syndrome we used males of hypertriacylglycerolemic rats in combination with high-fat-high-fructose diet. Rutin (100 mg/kg) and atorvastatin (50 mg/kg) were administered orally daily for 5 weeks. RESULTS: We determined biochemical parameters from blood: HDL-cholesterol, LDL-cholesterol, total cholesterol, triacylglycerols. Relaxation and contraction response of aorta was measured to determine vessel dysfunctions and possible predisposition to cardiovascular disease. The negative influence on cognitive functions could be associated with the development of metabolic cognitive syndrome. Therefore we aimed to monitor spatial memory by Morris water maze test. Both rutin and atorvastatin had a tendency to decrease levels of serum triacylglycerols, but only atorvastatin significantly reduced levels od LDL-cholesterol and increased HDL-cholesterol levels. Both compounds significantly reduced the phenylephrine-induced contractile response of the aorta and improved the relaxation response. Further, treated animals learned better compared to untreated rats in the Morris water maze. CONCLUSION: Based on our results we can assume that atorvastatin and rutin had positive effect on spatial memory and vessel reactivity. Atorvastatin optimized lipid profile of blood serum. Elsevier 2019-12 2019-10-11 /pmc/articles/PMC6921224/ /pubmed/31885479 http://dx.doi.org/10.1016/j.jsps.2019.10.002 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Micháliková, Dominika
Tyukos Kaprinay, Barbara
Lipták, Boris
Švík, Karol
Slovák, Lukáš
Sotníková, Ružena
Knezl, Vladimír
Gaspárová, Zdenka
Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
title Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
title_full Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
title_fullStr Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
title_full_unstemmed Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
title_short Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
title_sort natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921224/
https://www.ncbi.nlm.nih.gov/pubmed/31885479
http://dx.doi.org/10.1016/j.jsps.2019.10.002
work_keys_str_mv AT michalikovadominika naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT tyukoskaprinaybarbara naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT liptakboris naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT svikkarol naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT slovaklukas naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT sotnikovaruzena naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT knezlvladimir naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition
AT gasparovazdenka naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition